Mangalam Drugs & Organics Limited (BOM:532637)
India flag India · Delayed Price · Currency is INR
30.35
-0.13 (-0.43%)
At close: Sep 4, 2026

Mangalam Drugs & Organics Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
-44467.21-90.7212.7196.58
Depreciation & Amortization
182.23155.1665.72104.3697.78
Other Amortization
-10.919.25.534.71
Loss (Gain) From Sale of Assets
-0.41-0.740.70.031.74
Loss (Gain) From Sale of Investments
----0.12
Other Operating Activities
100.74120.46193.32138.97112.05
Change in Accounts Receivable
-12.24-111.2810.47-0.4378.22
Change in Inventory
360.28-151.62168.88-203.61-585.18
Change in Accounts Payable
-222.59249.86-199.04425.26111.52
Change in Other Net Operating Assets
77.7785.99-119.41-87.58239.55
Operating Cash Flow
41.78425.9439.13395.23257.09
Operating Cash Flow Growth
-90.19%988.64%-90.10%53.73%-6.68%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-118.99-202.01-118.33-279.14-276.69
Sale of Property, Plant & Equipment
1.747.280.0557.411.36
Investment in Securities
---0-2.07
Other Investing Activities
0000.010.01
Investing Cash Flow
-117.25-194.72-118.27-221.72-273.26

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
236.03-169.424.71-
Long-Term Debt Issued
----182.27
Total Debt Issued
236.03-169.424.71182.27
Short-Term Debt Repaid
--26.59---40.85
Long-Term Debt Repaid
-17.35-41.21-44.53-63.37-
Total Debt Repaid
-17.35-67.8-44.53-63.37-40.85
Net Debt Issued (Repaid)
218.68-67.8124.87-38.66141.41
Other Financing Activities
-162.08-149.33-72.6-127.51-111.62
Financing Cash Flow
56.59-217.1252.27-166.1729.79

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
---0-
Net Cash Flow
-18.8814.09-26.887.3413.63

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-77.22223.93-79.2116.09-19.6
Free Cash Flow Growth
-----
Free Cash Flow Margin
-3.33%7.05%-2.16%3.14%-0.43%
Free Cash Flow Per Share
-4.8814.15-5.007.33-1.24
Levered Free Cash Flow
26.75116.22-67.72-43.82-243.32
Unlevered Free Cash Flow
128.05186.1-2.6711.93-198.3

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
162.08149.3372.6127.51111.62
Cash Income Tax Paid
2.910.830.92-0.2688.08
Change in Working Capital
203.2272.95-139.11133.64-155.88